Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin.
AUTOR(ES)
Johnston, L A
RESUMO
Sodium butyrate reversibly inhibits muscle differentiation and blocks the expression of many muscle-specific genes in both proliferating myoblasts and differentiated myotubes. We investigated the role of the basic helix-loop-helix (bHLH) myogenic determinator proteins MyoD and myogenin in this inhibition. Our data suggest that both MyoD and myogenin are not able to function as transcriptional activators in the presence of butyrate, although both apparently retain the ability to bind DNA. Transcription of MyoD itself is extinguished in butyrate-treated myoblasts and myotubes, an effect that may be due to the inability of MyoD to autoactivate its own transcription. We present evidence that the HLH region of MyoD is essential for butyrate inhibition of MyoD. In contrast to MyoD and myogenin, butyrate does not inhibit the ubiquitous basic HLH protein E2-5 from functioning as a transcriptional activator.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=360446Documentos Relacionados
- The orphan nuclear receptor, COUP-TF II, inhibits myogenesis by post-transcriptional regulation of MyoD function: COUP-TF II directly interacts with p300 and myoD.
- MyoD and the regulation of myogenesis by helix-loop-helix proteins.
- Intramolecular Regulation of MyoD Activation Domain Conformation and Function†
- MyoD and myogenin act on the chicken myosin light-chain 1 gene as distinct transcriptional factors.
- c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation.
